Clinical Study On Virechana Effect Of Kalyanaka Guda Avaleha In Sthaulya

Clinical study on Virechana Effect of Kalyanaka Guda Avaleha in Sthaulya - CSVEKGAS

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/07/043704

Enrollment

Registered

2022-07-05

Start date

Unknown

Completion date

Unknown

Last updated

2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E669- Obesity, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients between age 18 to 60 years. 2. Patients diagnosed with obesity. 3. Patients having BMI 30 or above in males, BMI 28.6 or above in females. 4. Waist to Hip ratio 0.95 or above in male, 0.8 or above in female. 5. Patients fit for Virechana.

Exclusion criteria

Exclusion criteria: 1 Patient above 60 years, below 18 years will be excluded. 2. Pregnant women, lactating mothers will be excluded. 3. Patients having metabolic disturbances, hypertension, diabetes mellitus, other chronic acute diseases, IHD, Alcoholic patients, Hypothyroidism, Cushing Syndrome. 4.Patient Contraindicated for Virechana

Design outcomes

Primary

Measure	Time frame
Kalyanaka Guda Avaleha will have Virechana effects. Kalyanaka Guda Avaleha will be effective in reducing symptoms of SthaulyaTimepoint: 30 days study with two follow up on 8th day and 30th day of Virechana Vidhi	—

Secondary

Measure	Time frame
Kalyanak Guda Avaleha may also show reduction in Cholestrol levelsTimepoint: 30 days study with two follow up on 8th day and 30th day of Virechana Vidhi	—

Countries

India

Contacts

Public ContactSantosh Chavan

Bharati Vidyapeeth (Deemed to be) University, College of Ayurved

santosh.chavan@bharatividyapeeth.edu9822249807

Outcome results